IP Library Granted Patent US 7,005,097
Granted Patent B2
US 7,005,097 · App. 10/055,747 · Granted Feb 28, 2006

Medical devices employing chain extended polymers

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,005,097
App. No.
10/055,747
Granted
Feb 28, 2006
Kind
B2
Abstract

Medical devices such as catheters and balloons are formed from a thermoplastic polymer composition comprising a melt mixture product of at least one terminally reactive polymer and a chain extender.

Claims (34)

1. A method of preparing a medical device balloon comprising

preparing a polymer composition in melt form, and then

extruding the polymer composition to form tubing and

blowing a segment of the tubing to form the balloon,

without remelting the composition, wherein the step of preparing the polymer composition in melt form comprises

forming a melted reaction mixture comprising

a) at least one terminally reactive polymer and

b) a chain extender and

reacting the reaction mixture.

2. A method as in claim 1 wherein the terminally reactive polymer has at least one terminal active hydrogen and/or carboxylic acid group thereon.

3. A method as in claim 1 wherein the terminally reactive polymer is selected from the group consisting of polyesters; polyamides; polyurethanes; block copolymers incorporating a polyester, polyamide, polyurethane and/or polyether segment.

4. A method as in claim 3 wherein the polymer composition further comprises a polymer selected from the group consisting of polyolefins, poly(meth)acrylate esters, silicones, and organic rubbers.

5. A method as in claim 1 wherein the chain extender comprises a bis-lactam compound.

6. A method as in claim 5 wherein the bis-lactam compound is employed in said reaction mixture in an amount of from about 0.1% to about 5% by weight of the terminally reactive polymer.

7. A method as in claim 5 wherein the bis-lactam compound is a member selected from the group consisting of N,N′-isophthaloyl bis-caprolactam, N,N′-adipoyl bis-caprolactam, N,N′-terephthaloyl bis-laurolactam, N,N′-isophthaloyl bis-butyrolactam, carbonyl bis-caprolactam and mixtures thereof.

8. A method as in claim 1 wherein the chain extender comprises a bis-oxazoline and/or bis-oxazine compound.

9. A method as in claim 8 wherein the bisoxazoline and/or bisoxazine compound is a member selected from the group consisting of 2,2′-bis(2-oxazoline), 2,2-bis(4-methyl-2-oxazoline), 2,2′-bis(4-phenyl-2-oxazoline), 2,2′-bis(4-hexyloxazoline), 2,2′-p-phenylene bis(2-oxazoline), 2,2′-m-phenylene bis(2-oxazoline), 2,2′-tetramethylene bis(4,4′-dimethyl-2-oxazoline) 2,2′-bis(2-oxazine), 2,2-bis(4-methyl-2-oxazine), 2,2′-bis(4-phenyl-2-oxazine), 2,2′-bis(4-hexyloxazine), 2,2′-p-phenylene bis(2-oxazine), 2,2′m-phenylene bis(2-oxazine), 2,2-tetramethylene bis(4,4′-dimethyl-2-oxazine) and mixtures thereof.

10. A method as in claim 8 wherein the bis-oxazoline and/or bis-oxazine compound is employed in said reaction mixture in an amount of from about 0.1% to about 4% by weight of the terminally reactive polymer.

11. A method as in claim 1 wherein the chain extender is incorporated into said reaction mixture in an amount which increases polymer molecular weight but does not substantially promote or induce crosslinking.

12. A method of preparing a medical device comprising

preparing a polymer composition in melt form, and then

forming at least a portion of the device from the polymer composition

without remelting the composition, wherein the step of preparing the polymer composition in melt form comprises

forming a melted reaction mixture comprising

a) at least one terminally reactive thermoplastic polymer, and

b) a chain extender and

reacting the reaction mixture.

13. A method as in claim 12 wherein the terminally reactive polymer has at least one active hydrogen and/or carboxylic acid group thereon.

14. A method as in claim 12 wherein said step of forming at least a portion of the device from a thermoplastic polymer composition comprises extruding a tube of said polymer composition.

15. A method as in claim 14 wherein the medical device is a catheter or a balloom.

16. A method as in claim 12 wherein the medical device is a balloon, the method further comprising blowing a segment of the extruded tube at an elevated temperature and pressure to form the balloom.

17. A method as in claim 12 wherein the chain extender is incorporated into said reaction mixture in an amount which increases polymer molecular weight but does not substantially promote or induce crosslinking.

18. A method as in claim 14 wherein said tubing is extruded from an extruder and said reaction mixture is prepared in the extruder.

19. A method claim 1 wherein said tubing is extruded from an extruder and said reaction mixture is prepared in the extruder.

Assignments (1)
CHANGE OF NAME Recorded Nov 6, 2006
From: SCIMED LIFE SYSTEMS, INC.
To: BOSTON SCIENTIFIC SCIMED, INC.
Reel/Frame 018505/0868 →